Showing results (151-160 of 249) with videos related to

Sort By:
Pageof 25
Nucleic Acid Therapeutics|December 24, 2014
Quantitative PCR analysis of DNA aptamer pharmacokinetics in miceKatherine Perschbacher, John A Smestad, Justin P Peters, et al.
Biochemistry|January 23, 2002
Enzymatic properties of rat myelencephalon-specific proteaseSachiko I Blaber, Isobel A Scarisbrick, Matthew J Bernett, et al.
Plos Pathogens|March 3, 2012
Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunityKevin D Pavelko, Yanice Mendez-Fernandez, Michael P Bell, et al.
Expert Opinion on Biological Therapy|February 21, 2018
A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?Maria K Perwein, John A Smestad, Arthur E Warrington, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 7, 2006
Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DCFrank A Blocki, Suresh Radhakrishnan, Virginia P Van Keulen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 20, 2008
TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cellsSuresh Radhakrishnan, Laura N Arneson, Jadee L Upshaw, et al.
Neurologic Clinics|March 29, 2011
Pediatric multiple sclerosisTanuja Chitnis, Lauren Krupp, Ann Yeh, et al.
Lancet (London, England)|August 16, 2005
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchangeMark Keegan, Fatima König, Robyn McClelland, et al.
Plos One|September 4, 2010
CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosisChandra Deb, Reghann G Lafrance-Corey, William F Schmalstieg, et al.
Pageof 25